ARTICLE | Company News
Athersys, RTI deal
September 20, 2010 7:00 AM UTC
Athersys granted RTI an exclusive, worldwide license to use its multipotent adult progenitor cell (MPAC) technology to develop and commercialize biologic implants for orthopedic indications, including...